Show simple item record

A core outcome set for multimorbidity risk in individuals with cerebral palsy

dc.contributor.authorMcPhee, Patrick G.
dc.contributor.authorBenner, Joyce L.
dc.contributor.authorSanvido, Liam
dc.contributor.authorRoebroeck, Marij E.
dc.contributor.authorBerg-Emons, Rita J.
dc.contributor.authorSlot, Wilma M.
dc.contributor.authorVerschuren, Olaf
dc.contributor.authorHurvitz, Edward A.
dc.contributor.authorPeterson, Mark D.
dc.contributor.authorGorter, Jan Willem
dc.date.accessioned2022-06-01T20:28:39Z
dc.date.available2023-08-01 16:28:38en
dc.date.available2022-06-01T20:28:39Z
dc.date.issued2022-07
dc.identifier.citationMcPhee, Patrick G.; Benner, Joyce L.; Sanvido, Liam; Roebroeck, Marij E.; Berg-Emons, Rita J. ; Slot, Wilma M.; Verschuren, Olaf; Hurvitz, Edward A.; Peterson, Mark D.; Gorter, Jan Willem (2022). "A core outcome set for multimorbidity risk in individuals with cerebral palsy." Developmental Medicine & Child Neurology (7): 881-889.
dc.identifier.issn0012-1622
dc.identifier.issn1469-8749
dc.identifier.urihttps://hdl.handle.net/2027.42/172803
dc.description.abstractAimTo: (1) investigate the importance of outcome measurement instruments (OMIs) within a core outcome set (COS) for multimorbidity (at least two chronic health conditions) risk in individuals with cerebral palsy (CP); (2) investigate the feasibility of OMIs within the COS in international clinical research settings in adolescents and adults with CP; and (3) describe the associations between the COS data and Gross Motor Function Classification System (GMFCS) levels.MethodEighty-three individuals with CP completed a survey on health outcomes: physical behaviour, nutrition, sleep, endurance, body composition, blood pressure, blood lipids, and glucose. A cross-sectional study assessed the feasibility of the COS in 67 adolescents and adults with CP (mean age 30y, SD 15y 1mo, min–max: 14–68y, 52.2% male) at four centres. Prevalence of multimorbidity risk and associations with GMFCS levels are described.ResultsMost participants rated physical behaviour, nutrition, sleep, and endurance as very important. Body composition, blood pressure, nutrition, and sleep were highly feasible since data were collected in 88% or more participants who consented to having the assessments. Physical behaviour, cardiorespiratory endurance, and blood draws were collected in less than 60% of participants. Total time sedentary (ρ=0.53, p<0.01) and endurance (ρ=−0.46, p<0.01) were significantly associated with GMFCS level.InterpretationThe COS identified that most participants had poor sleep quality and endurance, did not have healthy diets, and showed increased sedentary behaviour. Individuals with CP valued these outcomes as most important, suggesting a need to assess these modifiable behaviours in this population. Objective measures of physical behaviour and cardiorespiratory endurance in the COS required additional personnel, time, and participant burden. We recommend that healthcare providers should perform a simpler first screen using questionnaire-based assessments and then focus the use of the remainder of the COS if required for the patient.ResumoUm desfecho central definido para risco de multimorbidade em indivíduos com paralisia cerebralObjetivo(1) Investigar a import-ncia dos instrumentos de medição de desfechos (IMD) dentro de um conjunto de desfechos principais (CDS) para risco de multimorbidade (pelo menos duas condições crônicas de saúde) em indivíduos com paralisia cerebral (PC); (2) Investigar a viabilidade de IMD dentro do CDS em cenários internacionais de pesquisa clínica em adolescentes e adultos com PC; e (3) Descrever as associações entre os dados do CDS e os níveis do Sistema de Classificação da Função Motora Grossa (GMFCS).MétodoOitenta e três indivíduos com PC completaram uma pesquisa sobre desfechos em saúde: comportamento físico, nutrição, sono, resistência, composição corporal, pressão arterial, lipídios no sangue e glicose. Um estudo transversal avaliou a viabilidade do COS em 67 adolescentes e adultos com PC (idade média de 30 anos, desvio padrão de 15 anos e 1 mês, min-max: 14-68 anos, 52,2% do sexo masculino) em quatro centros. São descritas a prevalência do risco de multimorbidade e as associações com os níveis de GMFCS.ResultadosA maioria dos participantes classificou o comportamento físico, nutrição, sono e resistência como muito importantes. Composição corporal, pressão arterial, nutrição e sono foram altamente viáveis, uma vez que os dados foram coletados em 88% ou mais dos participantes que consentiram em realizar as avaliações. Comportamento físico, resistência cardiorrespiratória e coleta de sangue foram coletados em menos de 60% dos participantes. O tempo total de sedentarismo (ρ = 0,53, p < 0,01) e resistência (ρ = −0,46, p < 0,01) foram significativamente associados ao nível de GMFCS.InterpretaçãoO CDS identificou que a maioria dos participantes tinha má qualidade e resistência do sono, não tinha dietas saudáveis e apresentava um comportamento sedentário aumentado. Indivíduos com PC valorizaram esses desfechos como mais importantes, sugerindo a necessidade de avaliar esses comportamentos modificáveis nessa população. Medidas objetivas de comportamento físico e resistência cardiorrespiratória no CDS exigiram pessoal adicional, tempo e sobrecarga do participante. Recomendamos que os profissionais de saúde realizem uma primeira triagem mais simples usando avaliações baseadas em questionários e, em seguida, concentrem o uso do restante do CDS, se necessário para o paciente.
dc.publisherWiley Periodicals, Inc.
dc.titleA core outcome set for multimorbidity risk in individuals with cerebral palsy
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelNeurosciences
dc.subject.hlbsecondlevelPediatrics
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/172803/1/dmcn15181.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/172803/2/dmcn15181_am.pdf
dc.identifier.doi10.1111/dmcn.15181
dc.identifier.sourceDevelopmental Medicine & Child Neurology
dc.identifier.citedreferencePalisano RJ, Rosenbaum P, Bartlett D, Livingston MH. Content validity of the expanded and revised Gross Motor Function Classification System. Dev Med Child Neurol. 2008; 50: 744 – 50.
dc.identifier.citedreferenceHimmelmann K, Sundh V. Survival with cerebral palsy over five decades in western S weden. Dev Med Child Neurol. 2015; 57: 762 – 7.
dc.identifier.citedreferenceBrooks JC, Strauss DJ, Shavelle RM, Tran LM, Rosenbloom L, Wu YW. Recent trends in cerebral palsy survival. Part I: period and cohort effects. Dev Med Child Neurol. 2014; 56: 1059 – 64.
dc.identifier.citedreferenceMcPhee PG, Macdonald MJ, Cheng JL, Dunford EC, Gorter JW. Emerging evidence for accelerated ageing and cardiovascular disease in individuals with cerebral palsy. J Rehabil Med. 2019; 51: 525 – 31.
dc.identifier.citedreferenceRyan JM, Allen E, Gormley J, Hurvitz EA, Peterson MD. The risk, burden, and management of non-communicable diseases in cerebral palsy: a scoping review. Dev Med Child Neurol. 2018; 60: 753 – 64.
dc.identifier.citedreferenceHilberink SR, Roebroeck ME, Nieuwstraten W, Jalink L, Verheijden J, Stam HJ. Health issues in young adults with cerebral palsy: towards a life-span perspective. J Rehabil Med. 2007; 39: 605 – 11.
dc.identifier.citedreferencePeterson MD, Ryan JM, Hurvitz EA, Mahmoudi E. Chronic conditions in adults with cerebral palsy. JAMA. 2015; 314: 2303 – 5.
dc.identifier.citedreferenceRyan JM, Forde C, Hussey JM, Gormley J. Comparison of patterns of physical activity and sedentary behavior between children with cerebral palsy and children with typical development. Phys Ther. 2015; 95: 1609 – 16.
dc.identifier.citedreferenceCremer N, Hurvitz EA, Peterson MD. Multimorbidity in middle-aged adults with cerebral palsy. Am J Med. 2017; 130: 744.e9–15.
dc.identifier.citedreferenceWhitney DG, Hurvitz EA, Ryan JM, Devlin MJ, Caird MS, French ZP, et al. Noncommunicable disease and multimorbidity in young adults with cerebral palsy. Clin Epidemiol. 2018; 10: 511.
dc.identifier.citedreferenceNoten S, van den Berg-Emons RJG, Thorpe DE, Heyn PC, Marciniak CM, McPhee PG, et al. Blood pressure in adults with cerebral palsy: a systematic review and meta-analysis of individual participant data. J Hypertens. 2021; 10: 1942.
dc.identifier.citedreferenceWhitney DG, Kamdar NS, Ng S, Hurvitz EA, Peterson MD. Prevalence of high-burden medical conditions and health care resource utilization and costs among adults with cerebral palsy. Clin Epidemiol. 2019; 11: 469.
dc.identifier.citedreferenceMcPhee PG, Benner JL, Balemans AC, Verschuren O, van den Berg-Emons RJ, Hurvitz EA, et al. Multimorbidity risk assessment in adolescents and adults with cerebral palsy: a protocol for establishing a core outcome set for clinical research and practice. Trials. 2019; 20: 176.
dc.identifier.citedreferenceBenner JL, McPhee PG, Gorter JW, Hurvitz EA, Peterson MD, Obeid J, et al. Focus on risk factors for cardiometabolic disease in cerebral palsy: toward a core set of outcome measurement instruments. Arch Phys Med Rehabil. 2019; 100: 2389 – 98.
dc.identifier.citedreferenceGuyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011; 64: 383 – 94.
dc.identifier.citedreferenceVerschuren O, Hulst RY, Voorman J, Pillen S, Luitwieler N, Dudink J, et al. 24-hour activity for children with cerebral palsy: a clinical practice guide. Dev Med Child Neurol. 2021; 63: 54 – 9.
dc.identifier.citedreferenceLavelle G, Noorkoiv M, Theis N, Korff T, Kilbride C, Baltzopoulos V, et al. Validity of the International Physical Activity Questionnaire Short Form (IPAQ-SF) as a measure of physical activity (PA) in young people with cerebral palsy: a cross-sectional study. Physiotherapy. 2020; 107: 209 – 15.
dc.identifier.citedreferencePeterson MD, Haapala HJ, Hurvitz EA. Predictors of cardiometabolic risk among adults with cerebral palsy. Arch Phys Med Rehabil. 2012; 93: 816 – 21.
dc.identifier.citedreferenceMcPhee PG, Claridge EA, Noorduyn SG, Gorter JW. Cardiovascular disease and related risk factors in adults with cerebral palsy: a systematic review. Dev Med Child Neurol. 2019; 61: 915 – 23.
dc.identifier.citedreferenceWhitney DG, Kamdar NS. Development of a new comorbidity index for adults with cerebral palsy and comparative assessment with common comorbidity indices. Dev Med Child Neurol. 2021; 63: 313 – 9.
dc.identifier.citedreferencevan der Slot W, Roebroeck ME, Nieuwenhuijsen C, Bergen MP, Stam HJ, Burdorf A, et al. Cardiovascular disease risk in adults with spastic bilateral cerebral palsy. J Rehabil Med. 2013; 45: 866 – 72.
dc.identifier.citedreferencePeterson MD, Hurvitz EA. Cerebral palsy grows up. Mayo Clin Proc. 2021; 96: 1404 – 6.
dc.identifier.citedreferenceAf Wåhlberg A, Poom L. An empirical test of nonresponse bias in internet surveys. Basic Appl Soc Psychol. 2015; 37: 336 – 47.
dc.working.doiNOen
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.